Altered muscle mitochondrial, inflammatory and trophic markers, and reduced exercise training adaptations in type 1 diabetes
Growing evidence of impaired skeletal muscle health in people with type 1 diabetes points toward the presence of a mild myopathy in this population. However, this myopathic condition is not yet well characterised and often overlooked, even though it might affect the whole‐body glucose homeostasis an...
Saved in:
Published in | The Journal of physiology Vol. 600; no. 6; pp. 1405 - 1418 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Wiley Subscription Services, Inc
01.03.2022
John Wiley and Sons Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Growing evidence of impaired skeletal muscle health in people with type 1 diabetes points toward the presence of a mild myopathy in this population. However, this myopathic condition is not yet well characterised and often overlooked, even though it might affect the whole‐body glucose homeostasis and the development of comorbidities. This study aimed to compare skeletal muscle adaptations and changes in glycaemic control after 12 weeks of combined resistance and aerobic (COMB) training between people with type 1 diabetes and healthy controls, and to determine whether the impaired muscle health in type 1 diabetes can affect the exercise‐induced adaptations. The COMB training intervention increased aerobic capacity and muscle strength in both healthy and type 1 diabetes sedentary participants, although these improvements were higher in the control group. Better glucose control, reduced glycaemic fluctuations and fewer hypoglycaemic events were recorded at post‐ compared to pre‐intervention in type 1 diabetes. Analysis of muscle biopsies showed an alteration of muscle markers of mitochondrial functions, inflammation, ageing and growth/atrophy compared to the control group. These muscular molecular differences were only partially modified by the COMB training and might explain the reduced exercise adaptation observed in type 1 diabetes. In brief, type 1 diabetes impairs many aspects of skeletal muscle health and might affect the exercise‐induced adaptations. Defining the magnitude of diabetic myopathy and the effect of exercise, including longer duration of the intervention, will drive the development of strategies to maximise muscle health in the type 1 diabetes population.
Key points
Type 1 diabetes negatively affects skeletal muscle health; however, the effect of structured exercise training on markers of mitochondrial function, inflammation and regeneration is not known.
Even though participants with type 1 diabetes and healthy control were comparable for cardiorespiratory fitness (V̇O2max${\dot{V}_{{{\rm{O}}_{\rm{2}}}{\rm{max}}}$) and muscle strength at baseline, molecular markers related to muscle health were decreased in type 1 diabetes.
After training, both groups increased V̇O2max${\dot{V}_{{{\rm{O}}_{\rm{2}}}{\rm{max}}}$ and muscle strength; however, a larger improvement was achieved by the control group.
The training intervention decreased glucose fluctuations and occurrence of hypoglycaemic events in type 1 diabetes, while signs of mild myopathy found in the muscle of participants with type 1 diabetes only partially improved after training
Improving muscle health by specific exercise protocols is of considerable clinical interest in therapeutic strategies for improving type 1 diabetes management and preventing or delaying long‐term complications.
figure legend The effect of type 1 diabetes on functional and molecular markers of skeletal muscle health in response to a training period and compared to healthy people. Ten people with type 1 diabetes and 10 healthy control subjects participated in a 12‐week, high‐intensity, combined exercise training programme. Muscle biopsies were collected before and after the training. At baseline, participants with type 1 diabetes exhibited a reduced level of mitochondrial DNA, proteins related to the oxidative phosphorylation (OXPHOS) system and reduced telomere length compared to control. These changes were detectable despite the two groups being comparable for body composition and functional measurements. The training programme improved glycaemic control but people with type 1 diabetes had a reduced adaptation in muscle force and aerobic capacity compared to control. The training period only partially improved the diabetes‐induced alterations of skeletal muscle health. Created with BioRender.com. |
---|---|
AbstractList | Growing evidence of impaired skeletal muscle health in people with type 1 diabetes points toward the presence of a mild myopathy in this population. However, this myopathic condition is not yet well characterised and often overlooked, even though it might affect the whole‐body glucose homeostasis and the development of comorbidities. This study aimed to compare skeletal muscle adaptations and changes in glycaemic control after 12 weeks of combined resistance and aerobic (COMB) training between people with type 1 diabetes and healthy controls, and to determine whether the impaired muscle health in type 1 diabetes can affect the exercise‐induced adaptations. The COMB training intervention increased aerobic capacity and muscle strength in both healthy and type 1 diabetes sedentary participants, although these improvements were higher in the control group. Better glucose control, reduced glycaemic fluctuations and fewer hypoglycaemic events were recorded at post‐ compared to pre‐intervention in type 1 diabetes. Analysis of muscle biopsies showed an alteration of muscle markers of mitochondrial functions, inflammation, ageing and growth/atrophy compared to the control group. These muscular molecular differences were only partially modified by the COMB training and might explain the reduced exercise adaptation observed in type 1 diabetes. In brief, type 1 diabetes impairs many aspects of skeletal muscle health and might affect the exercise‐induced adaptations. Defining the magnitude of diabetic myopathy and the effect of exercise, including longer duration of the intervention, will drive the development of strategies to maximise muscle health in the type 1 diabetes population.
Key points
Type 1 diabetes negatively affects skeletal muscle health; however, the effect of structured exercise training on markers of mitochondrial function, inflammation and regeneration is not known.
Even though participants with type 1 diabetes and healthy control were comparable for cardiorespiratory fitness (V̇O2max${\dot{V}_{{{\rm{O}}_{\rm{2}}}{\rm{max}}}$) and muscle strength at baseline, molecular markers related to muscle health were decreased in type 1 diabetes.
After training, both groups increased V̇O2max${\dot{V}_{{{\rm{O}}_{\rm{2}}}{\rm{max}}}$ and muscle strength; however, a larger improvement was achieved by the control group.
The training intervention decreased glucose fluctuations and occurrence of hypoglycaemic events in type 1 diabetes, while signs of mild myopathy found in the muscle of participants with type 1 diabetes only partially improved after training
Improving muscle health by specific exercise protocols is of considerable clinical interest in therapeutic strategies for improving type 1 diabetes management and preventing or delaying long‐term complications.
figure legend The effect of type 1 diabetes on functional and molecular markers of skeletal muscle health in response to a training period and compared to healthy people. Ten people with type 1 diabetes and 10 healthy control subjects participated in a 12‐week, high‐intensity, combined exercise training programme. Muscle biopsies were collected before and after the training. At baseline, participants with type 1 diabetes exhibited a reduced level of mitochondrial DNA, proteins related to the oxidative phosphorylation (OXPHOS) system and reduced telomere length compared to control. These changes were detectable despite the two groups being comparable for body composition and functional measurements. The training programme improved glycaemic control but people with type 1 diabetes had a reduced adaptation in muscle force and aerobic capacity compared to control. The training period only partially improved the diabetes‐induced alterations of skeletal muscle health. Created with BioRender.com. Growing evidence of impaired skeletal muscle health in people with type 1 diabetes points toward the presence of a mild myopathy in this population. However, this myopathic condition is not yet well characterised and often overlooked, even though it might affect the whole‐body glucose homeostasis and the development of comorbidities. This study aimed to compare skeletal muscle adaptations and changes in glycaemic control after 12 weeks of combined resistance and aerobic (COMB) training between people with type 1 diabetes and healthy controls, and to determine whether the impaired muscle health in type 1 diabetes can affect the exercise‐induced adaptations. The COMB training intervention increased aerobic capacity and muscle strength in both healthy and type 1 diabetes sedentary participants, although these improvements were higher in the control group. Better glucose control, reduced glycaemic fluctuations and fewer hypoglycaemic events were recorded at post‐ compared to pre‐intervention in type 1 diabetes. Analysis of muscle biopsies showed an alteration of muscle markers of mitochondrial functions, inflammation, ageing and growth/atrophy compared to the control group. These muscular molecular differences were only partially modified by the COMB training and might explain the reduced exercise adaptation observed in type 1 diabetes. In brief, type 1 diabetes impairs many aspects of skeletal muscle health and might affect the exercise‐induced adaptations. Defining the magnitude of diabetic myopathy and the effect of exercise, including longer duration of the intervention, will drive the development of strategies to maximise muscle health in the type 1 diabetes population.Key pointsType 1 diabetes negatively affects skeletal muscle health; however, the effect of structured exercise training on markers of mitochondrial function, inflammation and regeneration is not known.Even though participants with type 1 diabetes and healthy control were comparable for cardiorespiratory fitness (V̇O2max${\dot{V}_{{{\rm{O}}_{\rm{2}}}{\rm{max}}}$) and muscle strength at baseline, molecular markers related to muscle health were decreased in type 1 diabetes.After training, both groups increased V̇O2max${\dot{V}_{{{\rm{O}}_{\rm{2}}}{\rm{max}}}$ and muscle strength; however, a larger improvement was achieved by the control group.The training intervention decreased glucose fluctuations and occurrence of hypoglycaemic events in type 1 diabetes, while signs of mild myopathy found in the muscle of participants with type 1 diabetes only partially improved after trainingImproving muscle health by specific exercise protocols is of considerable clinical interest in therapeutic strategies for improving type 1 diabetes management and preventing or delaying long‐term complications. Abstract figure legend The effect of type 1 diabetes on functional and molecular markers of skeletal muscle health in response to a training period and compared to healthy people. Ten people with type 1 diabetes and 10 healthy control subjects participated in a 12‐week, high‐intensity, combined exercise training programme. Muscle biopsies were collected before and after the training. At baseline, participants with type 1 diabetes exhibited a reduced level of mitochondrial DNA, proteins related to the oxidative phosphorylation (OXPHOS) system and reduced telomere length compared to control. These changes were detectable despite the two groups being comparable for body composition and functional measurements. The training programme improved glycaemic control but people with type 1 diabetes had a reduced adaptation in muscle force and aerobic capacity compared to control. The training period only partially improved the diabetes‐induced alterations of skeletal muscle health. Created with BioRender.com. Growing evidence of impaired skeletal muscle health in people with type 1 diabetes points toward the presence of a mild myopathy in this population. However, this myopathic condition is not yet well characterised and often overlooked, even though it might affect the whole-body glucose homeostasis and the development of comorbidities. This study aimed to compare skeletal muscle adaptations and changes in glycaemic control after 12 weeks of combined resistance and aerobic (COMB) training between people with type 1 diabetes and healthy controls, and to determine whether the impaired muscle health in type 1 diabetes can affect the exercise-induced adaptations. The COMB training intervention increased aerobic capacity and muscle strength in both healthy and type 1 diabetes sedentary participants, although these improvements were higher in the control group. Better glucose control, reduced glycaemic fluctuations and fewer hypoglycaemic events were recorded at post- compared to pre-intervention in type 1 diabetes. Analysis of muscle biopsies showed an alteration of muscle markers of mitochondrial functions, inflammation, ageing and growth/atrophy compared to the control group. These muscular molecular differences were only partially modified by the COMB training and might explain the reduced exercise adaptation observed in type 1 diabetes. In brief, type 1 diabetes impairs many aspects of skeletal muscle health and might affect the exercise-induced adaptations. Defining the magnitude of diabetic myopathy and the effect of exercise, including longer duration of the intervention, will drive the development of strategies to maximise muscle health in the type 1 diabetes population. KEY POINTS: Type 1 diabetes negatively affects skeletal muscle health; however, the effect of structured exercise training on markers of mitochondrial function, inflammation and regeneration is not known. Even though participants with type 1 diabetes and healthy control were comparable for cardiorespiratory fitness ( ) and muscle strength at baseline, molecular markers related to muscle health were decreased in type 1 diabetes. After training, both groups increased and muscle strength; however, a larger improvement was achieved by the control group. The training intervention decreased glucose fluctuations and occurrence of hypoglycaemic events in type 1 diabetes, while signs of mild myopathy found in the muscle of participants with type 1 diabetes only partially improved after training Improving muscle health by specific exercise protocols is of considerable clinical interest in therapeutic strategies for improving type 1 diabetes management and preventing or delaying long-term complications. Growing evidence of impaired skeletal muscle health in people with type 1 diabetes points toward the presence of a mild myopathy in this population. However, this myopathic condition is not yet well characterised and often overlooked, even though it might affect the whole-body glucose homeostasis and the development of comorbidities. This study aimed to compare skeletal muscle adaptations and changes in glycaemic control after 12 weeks of combined resistance and aerobic (COMB) training between people with type 1 diabetes and healthy controls, and to determine whether the impaired muscle health in type 1 diabetes can affect the exercise-induced adaptations. The COMB training intervention increased aerobic capacity and muscle strength in both healthy and type 1 diabetes sedentary participants, although these improvements were higher in the control group. Better glucose control, reduced glycaemic fluctuations and fewer hypoglycaemic events were recorded at post- compared to pre-intervention in type 1 diabetes. Analysis of muscle biopsies showed an alteration of muscle markers of mitochondrial functions, inflammation, ageing and growth/atrophy compared to the control group. These muscular molecular differences were only partially modified by the COMB training and might explain the reduced exercise adaptation observed in type 1 diabetes. In brief, type 1 diabetes impairs many aspects of skeletal muscle health and might affect the exercise-induced adaptations. Defining the magnitude of diabetic myopathy and the effect of exercise, including longer duration of the intervention, will drive the development of strategies to maximise muscle health in the type 1 diabetes population. KEY POINTS: Type 1 diabetes negatively affects skeletal muscle health; however, the effect of structured exercise training on markers of mitochondrial function, inflammation and regeneration is not known. Even though participants with type 1 diabetes and healthy control were comparable for cardiorespiratory fitness ( V̇O2max${\dot{V}_{{{\rm{O}}_{\rm{2}}}{\rm{max}}}$ ) and muscle strength at baseline, molecular markers related to muscle health were decreased in type 1 diabetes. After training, both groups increased V̇O2max${\dot{V}_{{{\rm{O}}_{\rm{2}}}{\rm{max}}}$ and muscle strength; however, a larger improvement was achieved by the control group. The training intervention decreased glucose fluctuations and occurrence of hypoglycaemic events in type 1 diabetes, while signs of mild myopathy found in the muscle of participants with type 1 diabetes only partially improved after training Improving muscle health by specific exercise protocols is of considerable clinical interest in therapeutic strategies for improving type 1 diabetes management and preventing or delaying long-term complications.Growing evidence of impaired skeletal muscle health in people with type 1 diabetes points toward the presence of a mild myopathy in this population. However, this myopathic condition is not yet well characterised and often overlooked, even though it might affect the whole-body glucose homeostasis and the development of comorbidities. This study aimed to compare skeletal muscle adaptations and changes in glycaemic control after 12 weeks of combined resistance and aerobic (COMB) training between people with type 1 diabetes and healthy controls, and to determine whether the impaired muscle health in type 1 diabetes can affect the exercise-induced adaptations. The COMB training intervention increased aerobic capacity and muscle strength in both healthy and type 1 diabetes sedentary participants, although these improvements were higher in the control group. Better glucose control, reduced glycaemic fluctuations and fewer hypoglycaemic events were recorded at post- compared to pre-intervention in type 1 diabetes. Analysis of muscle biopsies showed an alteration of muscle markers of mitochondrial functions, inflammation, ageing and growth/atrophy compared to the control group. These muscular molecular differences were only partially modified by the COMB training and might explain the reduced exercise adaptation observed in type 1 diabetes. In brief, type 1 diabetes impairs many aspects of skeletal muscle health and might affect the exercise-induced adaptations. Defining the magnitude of diabetic myopathy and the effect of exercise, including longer duration of the intervention, will drive the development of strategies to maximise muscle health in the type 1 diabetes population. KEY POINTS: Type 1 diabetes negatively affects skeletal muscle health; however, the effect of structured exercise training on markers of mitochondrial function, inflammation and regeneration is not known. Even though participants with type 1 diabetes and healthy control were comparable for cardiorespiratory fitness ( V̇O2max${\dot{V}_{{{\rm{O}}_{\rm{2}}}{\rm{max}}}$ ) and muscle strength at baseline, molecular markers related to muscle health were decreased in type 1 diabetes. After training, both groups increased V̇O2max${\dot{V}_{{{\rm{O}}_{\rm{2}}}{\rm{max}}}$ and muscle strength; however, a larger improvement was achieved by the control group. The training intervention decreased glucose fluctuations and occurrence of hypoglycaemic events in type 1 diabetes, while signs of mild myopathy found in the muscle of participants with type 1 diabetes only partially improved after training Improving muscle health by specific exercise protocols is of considerable clinical interest in therapeutic strategies for improving type 1 diabetes management and preventing or delaying long-term complications. |
Author | Minnock, Dean Saltarelli, Roberta Annibalini, Giosuè Valli, Giacomo Krause, Mauricio Barbieri, Elena De Vito, Giuseppe |
AuthorAffiliation | 2 Department of Biomolecular Sciences University of Urbino Carlo Bo Urbino Italy 4 Department of Physiology Federal University of Rio Grande do Sul Porto Alegre Brazil 1 School of Public Health Physiotherapy and Sports Science University College Dublin Dublin Ireland 3 Neuromuscular Physiology Laboratory Department of Biomedical Sciences University of Padova Padova Italy |
AuthorAffiliation_xml | – name: 3 Neuromuscular Physiology Laboratory Department of Biomedical Sciences University of Padova Padova Italy – name: 4 Department of Physiology Federal University of Rio Grande do Sul Porto Alegre Brazil – name: 1 School of Public Health Physiotherapy and Sports Science University College Dublin Dublin Ireland – name: 2 Department of Biomolecular Sciences University of Urbino Carlo Bo Urbino Italy |
Author_xml | – sequence: 1 givenname: Dean orcidid: 0000-0001-9549-0839 surname: Minnock fullname: Minnock, Dean organization: University College Dublin – sequence: 2 givenname: Giosuè orcidid: 0000-0002-6914-4905 surname: Annibalini fullname: Annibalini, Giosuè organization: University of Urbino Carlo Bo – sequence: 3 givenname: Giacomo orcidid: 0000-0002-5221-580X surname: Valli fullname: Valli, Giacomo email: giacomo.valli@phd.unipd.it organization: University of Padova – sequence: 4 givenname: Roberta orcidid: 0000-0002-6375-127X surname: Saltarelli fullname: Saltarelli, Roberta organization: University of Urbino Carlo Bo – sequence: 5 givenname: Mauricio orcidid: 0000-0001-9814-742X surname: Krause fullname: Krause, Mauricio organization: Federal University of Rio Grande do Sul – sequence: 6 givenname: Elena orcidid: 0000-0002-3480-7983 surname: Barbieri fullname: Barbieri, Elena organization: University of Urbino Carlo Bo – sequence: 7 givenname: Giuseppe orcidid: 0000-0002-6855-9180 surname: De Vito fullname: De Vito, Giuseppe organization: University of Padova |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34995365$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kUtr3DAURkVJaSZpob-gCLrpIk71sCRrUwihrxBoFrMXinydUWpLrmSnHciPj6Yzkz5oNxJI5x6-e-8ROggxAEIvKTmllPK3F1esYTXnT9CC1lJXSml-gBaEMFZxJeghOsr5lhDKidbP0CGvtRZcigW6P-snSNDiYc6uBzz4KbpVDG3ytj_BPnS9HQY7xbTGNrR4SnFceYcHm75Cyic_H0v97IoDfkByPkOhrA8-3GDb2nGyk48hFxee1iNgiltvr2GC_Bw97Wyf4cXuPkbLD--X55-qyy8fP5-fXVau5ppWnZKSKKq0dAxo07aqFgJ0DUIQBq0ERTvhFK2JllxKxZRQ3AoA2nad7vgxerfVjvP1AK2DUPL1Zky-dLE20Xrz50_wK3MT74zmRCpVF8GbnSDFbzPkyQw-O-h7GyDO2TBJG8ZZo0lBX_-F3sY5hdJdoXjTiHJuqFe_J3qMst9LAU63gEsx5wSdcX47x81oe0OJ2Sze7Bf_K-Jjwd75D3Tn_u57WP-XM8uLK1rrmvIHSL27ow |
CitedBy_id | crossref_primary_10_1016_j_intimp_2023_110883 crossref_primary_10_1113_JP282964 crossref_primary_10_1016_j_jshs_2024_02_002 crossref_primary_10_1007_s00125_024_06153_0 crossref_primary_10_1249_JES_0000000000000331 crossref_primary_10_1371_journal_pone_0303448 crossref_primary_10_1113_JP287589 crossref_primary_10_3390_ijms24032973 crossref_primary_10_1113_JP285685 crossref_primary_10_1002_jcp_31419 crossref_primary_10_1038_s41574_022_00756_6 crossref_primary_10_1113_JP282800 crossref_primary_10_1080_13813455_2024_2410791 crossref_primary_10_1177_11795514241244872 crossref_primary_10_1155_2024_5549762 crossref_primary_10_3389_fphys_2024_1466148 crossref_primary_10_1007_s00421_024_05595_z crossref_primary_10_3390_nu15194279 |
Cites_doi | 10.1007/s13402-015-0263-3 10.3389/fnut.2019.00146 10.1016/j.amjmed.2005.10.049 10.1210/clinem/dgab261 10.1016/j.numecd.2007.01.012 10.1089/ars.2009.2531 10.18632/oncotarget.16726 10.1177/193229680800200614 10.1016/j.jdiacomp.2018.09.008 10.1007/s00125-021-05540-1 10.1016/j.numecd.2020.12.006 10.2337/dc19-1125 10.1007/s00424-009-0728-1 10.1089/dia.2010.0247 10.3389/fnut.2019.00075 10.14814/phy2.14158 10.1002/iub.21 10.1016/j.mehy.2017.05.033 10.1249/JES.0000000000000184 10.1097/WCO.0000000000000479 10.1038/ng1180 10.1093/nar/30.10.e47 10.1371/journal.pone.0070971 10.1016/j.biochi.2019.07.014 10.1097/MOL.0b013e328328d0a4 10.1016/j.cmet.2017.04.010 10.1111/j.1600-0838.2009.00966.x 10.1113/jphysiol.2005.097154 10.1249/MSS.0b013e3181b07d12 10.1007/s00125-018-4602-6 10.1111/j.1532-5415.2004.52014.x 10.1016/S2213-8587(17)30014-1 10.1007/s00421-020-04491-6 10.2337/dc14-1166 10.4093/dmj.2017.41.5.327 10.3389/fendo.2020.00033 10.1074/jbc.M207129200 10.1113/jphysiol.2006.109512 10.1016/S0140-6736(06)68341-4 10.2337/db15-1577 |
ContentType | Journal Article |
Copyright | 2022 The Authors. published by John Wiley & Sons Ltd on behalf of The Physiological Society. 2022 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society. 2022. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: 2022 The Authors. published by John Wiley & Sons Ltd on behalf of The Physiological Society. – notice: 2022 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society. – notice: 2022. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | 24P AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QP 7QR 7TK 7TS 8FD FR3 P64 7X8 5PM |
DOI | 10.1113/JP282433 |
DatabaseName | Wiley Online Library Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Neurosciences Abstracts Physical Education Index Technology Research Database Engineering Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Technology Research Database Chemoreception Abstracts Engineering Research Database Calcium & Calcified Tissue Abstracts Neurosciences Abstracts Physical Education Index Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitleList | Technology Research Database MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology |
DocumentTitleAlternate | D. Minnock and others |
EISSN | 1469-7793 |
EndPage | 1418 |
ExternalDocumentID | PMC9306774 34995365 10_1113_JP282433 TJP14941 |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: Irish Research Council funderid: EBPPG/2016/278 – fundername: ; grantid: EBPPG/2016/278 |
GroupedDBID | --- -DZ -~X .3N .GA 05W 0R~ 10A 123 18M 1OC 24P 29L 2WC 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAFWJ AAHHS AAHQN AAIPD AAMNL AANLZ AAONW AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABITZ ABIVO ABJNI ABOCM ABPPZ ABPVW ABQWH ABXGK ACAHQ ACCFJ ACCZN ACFBH ACGFO ACGFS ACGOF ACIWK ACMXC ACNCT ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEEZP AEGXH AEIGN AEIMD AEQDE AEUYR AEYWJ AFBPY AFEBI AFFPM AFGKR AFWVQ AFZJQ AGHNM AGYGG AHBTC AI. AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB AOIJS ATUGU AZBYB AZVAB BAFTC BAWUL BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM E3Z EBS EMOBN EX3 F00 F01 F04 F5P FIJ FUBAC G-S G.N GODZA GX1 H.X HGLYW HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D Q.N Q11 QB0 R.K ROL RPM RX1 SUPJJ TEORI TLM TN5 TR2 UB1 UPT V8K VH1 W8F W8V W99 WBKPD WH7 WIH WIJ WIK WIN WNSPC WOHZO WOQ WOW WQJ WXI WXSBR WYISQ XG1 YBU YHG YKV YQT YSK YZZ ZZTAW ~IA ~WT .55 .GJ .Y3 0YM 31~ 3EH 3O- AASGY AAYJJ AAYXX ADXHL AFFNX C1A CAG CHEAL CITATION COF EJD FA8 H13 HF~ H~9 LW6 MVM NEJ OHT RIG UKR WHG X7M XOL YXB YYP ZGI ZXP 1OB AEUQT AFPWT CGR CUY CVF ECM EIF IPNFZ NPM PKN SAMSI WRC 7QP 7QR 7TK 7TS 8FD FR3 P64 7X8 5PM |
ID | FETCH-LOGICAL-c4391-f766071796c2e18dd7455e94e5502ed6e71f5c714096366727573a5ee1dff9f3 |
IEDL.DBID | DR2 |
ISSN | 0022-3751 1469-7793 |
IngestDate | Thu Aug 21 18:31:43 EDT 2025 Fri Jul 11 16:04:46 EDT 2025 Fri Jul 25 12:21:27 EDT 2025 Wed Feb 19 02:26:42 EST 2025 Thu Apr 24 23:01:22 EDT 2025 Tue Jul 01 04:29:35 EDT 2025 Wed Jun 11 08:25:46 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | type 1 diabetes muscle adaptation glucose variability hypoglycaemia myopathy exercise physiology mitochondria exercise |
Language | English |
License | Attribution 2022 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4391-f766071796c2e18dd7455e94e5502ed6e71f5c714096366727573a5ee1dff9f3 |
Notes | Edited by: Michael Hogan & Bettina Mittendorfer https://doi.org/10.1113/JP282800 https://doi.org/10.1113/JP282433#support‐information‐section The peer review history is available in the Supporting Information section of this article Linked articles: This article is highlighted in a Perspectives article by Hawke. To read this article, visit . D. Minnock and G. Annibalini are co‐first authors. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Linked articles: This article is highlighted in a Perspectives article by Hawke. To read this article, visit https://doi.org/10.1113/JP282800. The peer review history is available in the Supporting Information section of this article (https://doi.org/10.1113/JP282433#support‐information‐section). |
ORCID | 0000-0001-9814-742X 0000-0002-6914-4905 0000-0002-3480-7983 0000-0002-5221-580X 0000-0001-9549-0839 0000-0002-6375-127X 0000-0002-6855-9180 |
OpenAccessLink | https://proxy.k.utb.cz/login?url=https://onlinelibrary.wiley.com/doi/abs/10.1113%2FJP282433 |
PMID | 34995365 |
PQID | 2638852630 |
PQPubID | 1086388 |
PageCount | 14 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_9306774 proquest_miscellaneous_2618232890 proquest_journals_2638852630 pubmed_primary_34995365 crossref_citationtrail_10_1113_JP282433 crossref_primary_10_1113_JP282433 wiley_primary_10_1113_JP282433_TJP14941 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-03-01 |
PublicationDateYYYYMMDD | 2022-03-01 |
PublicationDate_xml | – month: 03 year: 2022 text: 2022-03-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London – name: Hoboken |
PublicationTitle | The Journal of physiology |
PublicationTitleAlternate | J Physiol |
PublicationYear | 2022 |
Publisher | Wiley Subscription Services, Inc John Wiley and Sons Inc |
Publisher_xml | – name: Wiley Subscription Services, Inc – name: John Wiley and Sons Inc |
References | 2007; 17 2017; 5 2010; 12 2019; 7 2017; 8 2017; 41 2015; 38 2021; 64 2006; 119 2019; 6 2009; 20 2002; 30 2017; 25 2020; 120 2021; 106 1998 2011; 13 2020; 11 2018; 61 2016; 39 2013; 8 2008; 2 2003; 278 2006; 574 2019; 166 2003; 34 2004; 52 2010; 42 2010; 20 2017; 30 2021; 31 2010; 459 2019; 47 2016; 65 2005; 569 2020; 43 2018; 32 2008; 60 2017; 104 2006; 367 e_1_2_5_27_1 e_1_2_5_28_1 e_1_2_5_25_1 e_1_2_5_26_1 e_1_2_5_23_1 e_1_2_5_24_1 e_1_2_5_21_1 e_1_2_5_22_1 e_1_2_5_29_1 e_1_2_5_42_1 e_1_2_5_20_1 e_1_2_5_41_1 e_1_2_5_40_1 e_1_2_5_15_1 e_1_2_5_38_1 e_1_2_5_14_1 e_1_2_5_39_1 e_1_2_5_17_1 e_1_2_5_36_1 e_1_2_5_9_1 e_1_2_5_16_1 e_1_2_5_37_1 e_1_2_5_8_1 e_1_2_5_11_1 e_1_2_5_34_1 e_1_2_5_7_1 e_1_2_5_10_1 e_1_2_5_35_1 e_1_2_5_6_1 e_1_2_5_13_1 e_1_2_5_32_1 e_1_2_5_5_1 e_1_2_5_12_1 e_1_2_5_33_1 e_1_2_5_4_1 e_1_2_5_3_1 e_1_2_5_2_1 e_1_2_5_19_1 e_1_2_5_18_1 e_1_2_5_30_1 e_1_2_5_31_1 |
References_xml | – volume: 30 start-page: 545 year: 2017 end-page: 552 article-title: Diabetic Myopathy: current molecular understanding of this novel neuromuscular disorder publication-title: Curr Opin Neurol – volume: 459 start-page: 259 year: 2010 end-page: 268 article-title: Telomere biology in healthy aging and disease publication-title: Pflugers Arch – volume: 8 year: 2013 article-title: Impaired macrophage and satellite cell infiltration occurs in a muscle‐specific fashion following injury in diabetic skeletal muscle publication-title: PLoS One – volume: 34 start-page: 267 year: 2003 end-page: 273 article-title: PGC‐1α‐responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes publication-title: Nat Genet – volume: 367 start-page: 847 year: 2006 end-page: 858 article-title: Type 1 diabetes publication-title: Lancet – volume: 119 year: 2006 article-title: Inflammatory markers and loss of muscle mass (sarcopenia) and strength publication-title: Am J Med – volume: 6 start-page: 75 year: 2019 article-title: The impact of step reduction on muscle health in aging: protein and exercise as countermeasures publication-title: Front Nutr – volume: 120 start-page: 2677 year: 2020 end-page: 2691 article-title: Effects of acute aerobic, resistance and combined exercises on 24‐h glucose variability and skeletal muscle signalling responses in type 1 diabetics publication-title: Eur J Appl Physiol – volume: 30 start-page: 47e year: 2002 article-title: Telomere measurement by quantitative PCR publication-title: Nucleic Acids Res – volume: 569 start-page: 223 year: 2005 end-page: 228 article-title: Exercise rapidly increase eukaryotic elongation factor 2 phosphorylation in skeletal muscle of men publication-title: J Physiol – volume: 32 start-page: 1124 year: 2018 end-page: 1132 article-title: Glycemic, inflammatory and oxidative stress responses to different high‐intensity training protocols in type 1 diabetes: a randomized clinical trial publication-title: J Diabetes Complications – volume: 31 start-page: 705 year: 2021 end-page: 716 article-title: Delayed effect of different exercise modalities on glycaemic control in type 1 diabetes mellitus: a systematic review and meta‐analysis publication-title: Nutr Metab Cardiovasc Dis – volume: 574 start-page: 33 year: 2006 end-page: 39 article-title: The role of AMP‐activated protein kinase in mitochondrial biogenesis publication-title: J Physiol – volume: 5 start-page: 377 year: 2017 end-page: 390 article-title: Exercise management in type 1 diabetes: a consensus statement publication-title: Lancet Diabetes Endocrinol – volume: 13 start-page: 921 year: 2011 end-page: 928 article-title: Normal reference range for mean tissue glucose and glycemic variability derived from continuous glucose monitoring for subjects without diabetes in different ethnic groups publication-title: Diabetes Technol Ther – volume: 20 start-page: 98 year: 2009 end-page: 105 article-title: PGC‐1α, SIRT1 and AMPK, an energy sensing network that controls energy expenditure publication-title: Curr Opin Lipidol – volume: 17 start-page: 383 year: 2007 end-page: 393 article-title: Fine needle aspiration coupled with real‐time PCR: a painless methodology to study adaptive functional changes in skeletal muscle publication-title: Nutr Metab Cardiovasc Dis – volume: 20 start-page: 39 year: 2010 end-page: 48 article-title: The biology of satellite cells and telomeres in human skeletal muscle: effects of aging and physical activity publication-title: Scand J Med Sci Sports – volume: 166 start-page: 251 year: 2019 end-page: 269 article-title: Skeletal muscle atrogenes: from rodent models to human pathologies publication-title: Biochimie – year: 1998 – volume: 106 start-page: 2405 year: 2021 end-page: 2422 article-title: Impaired function and altered morphology in the skeletal muscles of adult men and women with type 1 diabetes publication-title: J Clin Endocrinol Metab – volume: 25 start-page: 1147 year: 2017 end-page: 1159.e10 article-title: Activation of skeletal muscle AMPK promotes glucose disposal and glucose lowering in non‐human primates and mice publication-title: Cell Metab – volume: 43 start-page: 209 year: 2020 end-page: 218 article-title: Muscle oxygen supply and use in type 1 diabetes, from ambient air to the mitochondrial respiratory chain: is there a limiting step? publication-title: Diabetes Care – volume: 11 start-page: 33 year: 2020 article-title: Growth hormone(s), testosterone, insulin‐like growth factors, and cortisol: roles and integration for cellular development and growth with exercise publication-title: Front Endocrinol – volume: 278 start-page: 2294 year: 2003 end-page: 2303 article-title: Tumor necrosis factor‐regulated biphasic activation of NF‐κB is required for cytokine‐induced loss of skeletal muscle gene products publication-title: J Biol Chem – volume: 38 start-page: 82 year: 2015 end-page: 90 article-title: Hyperglycemia predicts persistently lower muscle strength with aging publication-title: Diabetes Care – volume: 60 start-page: 145 year: 2008 end-page: 153 article-title: Signaling mechanisms in skeletal muscle: acute responses and chronic adaptations to exercise publication-title: IUBMB Life – volume: 39 start-page: 149 year: 2016 end-page: 159 article-title: Human IGF1 pro‐forms induce breast cancer cell proliferation via the IGF1 receptor publication-title: Cell Oncol – volume: 2 start-page: 1061 year: 2008 end-page: 1065 article-title: Group of signs: a new method to evaluate glycemic variability publication-title: J Diabetes Sci Technol – volume: 6 start-page: 146 year: 2019 article-title: The role of the IGF‐1 signaling cascade in muscle protein synthesis and anabolic resistance in aging skeletal muscle publication-title: Front Nutr – volume: 41 start-page: 327 year: 2017 article-title: Skeletal muscle thermogenesis and its role in whole body energy metabolism publication-title: Diabetes Metab J – volume: 104 start-page: 147 year: 2017 end-page: 153 article-title: Exercise for type 1 diabetes mellitus management: gneral considerations and new directions publication-title: Med Hypotheses – volume: 52 start-page: 80 year: 2004 end-page: 85 article-title: The healthcare costs of sarcopenia in the United States publication-title: J Am Geriatr Soc – volume: 61 start-page: 1411 year: 2018 end-page: 1423 article-title: Altered mitochondrial bioenergetics and ultrastructure in the skeletal muscle of young adults with type 1 diabetes publication-title: Diabetologia – volume: 65 start-page: 3053 year: 2016 end-page: 3061 article-title: Decreased satellite cell number and function in humans and mice with type 1 diabetes is the result of altered notch signaling publication-title: Diabetes – volume: 12 start-page: 537 year: 2010 end-page: 577 article-title: Mitochondrial dysfunction in diabetes: from molecular mechanisms to functional significance and therapeutic opportunities publication-title: Antioxid Redox Signal – volume: 8 start-page: 45008 year: 2017 end-page: 45019 article-title: Physical activity and telomere length: impact of aging and potential mechanisms of action publication-title: Oncotarget – volume: 42 start-page: 50 year: 2010 end-page: 57 article-title: Insulin‐like growth factor I signaling in skeletal muscle and the potential for cytokine interactions publication-title: Med Sci Sport Exerc – volume: 64 start-page: 2517 year: 2021 end-page: 2533 article-title: Normal to enhanced intrinsic mitochondrial respiration in skeletal muscle of middle‐ to older‐aged women and men with uncomplicated type 1 diabetes publication-title: Diabetologia – volume: 47 start-page: 98 year: 2019 end-page: 107 article-title: Considering type 1 diabetes as a form of accelerated muscle aging publication-title: Exerc Sport Sci Rev – volume: 7 year: 2019 article-title: Insulin and exercise improved muscle function in rats with severe burns and hindlimb unloading publication-title: Physiol Rep – ident: e_1_2_5_10_1 doi: 10.1007/s13402-015-0263-3 – ident: e_1_2_5_4_1 doi: 10.3389/fnut.2019.00146 – ident: e_1_2_5_37_1 doi: 10.1016/j.amjmed.2005.10.049 – ident: e_1_2_5_11_1 doi: 10.1210/clinem/dgab261 – ident: e_1_2_5_15_1 doi: 10.1016/j.numecd.2007.01.012 – ident: e_1_2_5_38_1 doi: 10.1089/ars.2009.2531 – ident: e_1_2_5_3_1 doi: 10.18632/oncotarget.16726 – ident: e_1_2_5_42_1 doi: 10.1177/193229680800200614 – ident: e_1_2_5_14_1 doi: 10.1016/j.jdiacomp.2018.09.008 – ident: e_1_2_5_28_1 doi: 10.1007/s00125-021-05540-1 – ident: e_1_2_5_41_1 doi: 10.1016/j.numecd.2020.12.006 – ident: e_1_2_5_16_1 doi: 10.2337/dc19-1125 – ident: e_1_2_5_30_1 doi: 10.1007/s00424-009-0728-1 – ident: e_1_2_5_17_1 doi: 10.1089/dia.2010.0247 – ident: e_1_2_5_31_1 doi: 10.3389/fnut.2019.00075 – ident: e_1_2_5_39_1 doi: 10.14814/phy2.14158 – ident: e_1_2_5_35_1 doi: 10.1002/iub.21 – ident: e_1_2_5_13_1 doi: 10.1016/j.mehy.2017.05.033 – ident: e_1_2_5_25_1 doi: 10.1249/JES.0000000000000184 – ident: e_1_2_5_27_1 doi: 10.1097/WCO.0000000000000479 – ident: e_1_2_5_29_1 doi: 10.1038/ng1180 – ident: e_1_2_5_7_1 doi: 10.1093/nar/30.10.e47 – ident: e_1_2_5_22_1 doi: 10.1371/journal.pone.0070971 – ident: e_1_2_5_40_1 doi: 10.1016/j.biochi.2019.07.014 – ident: e_1_2_5_6_1 doi: 10.1097/MOL.0b013e328328d0a4 – ident: e_1_2_5_8_1 doi: 10.1016/j.cmet.2017.04.010 – ident: e_1_2_5_5_1 – ident: e_1_2_5_19_1 doi: 10.1111/j.1600-0838.2009.00966.x – ident: e_1_2_5_36_1 doi: 10.1113/jphysiol.2005.097154 – ident: e_1_2_5_2_1 doi: 10.1249/MSS.0b013e3181b07d12 – ident: e_1_2_5_26_1 doi: 10.1007/s00125-018-4602-6 – ident: e_1_2_5_18_1 doi: 10.1111/j.1532-5415.2004.52014.x – ident: e_1_2_5_34_1 doi: 10.1016/S2213-8587(17)30014-1 – ident: e_1_2_5_24_1 doi: 10.1007/s00421-020-04491-6 – ident: e_1_2_5_20_1 doi: 10.2337/dc14-1166 – ident: e_1_2_5_32_1 doi: 10.4093/dmj.2017.41.5.327 – ident: e_1_2_5_21_1 doi: 10.3389/fendo.2020.00033 – ident: e_1_2_5_23_1 doi: 10.1074/jbc.M207129200 – ident: e_1_2_5_33_1 doi: 10.1113/jphysiol.2006.109512 – ident: e_1_2_5_9_1 doi: 10.1016/S0140-6736(06)68341-4 – ident: e_1_2_5_12_1 doi: 10.2337/db15-1577 |
SSID | ssj0013099 |
Score | 2.4817379 |
Snippet | Growing evidence of impaired skeletal muscle health in people with type 1 diabetes points toward the presence of a mild myopathy in this population. However,... Abstract figure legend The effect of type 1 diabetes on functional and molecular markers of skeletal muscle health in response to a training period and... |
SourceID | pubmedcentral proquest pubmed crossref wiley |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1405 |
SubjectTerms | Adaptation Aerobic capacity Aging Atrophy Biomarkers - metabolism Biopsy Cardiorespiratory fitness Diabetes Diabetes mellitus (insulin dependent) Diabetes Mellitus, Type 1 - metabolism Exercise Exercise - physiology Fitness training programs Glucose Glucose - metabolism glucose variability Homeostasis Humans hypoglycaemia Hypoglycemia Hypoglycemic Agents Inflammation Inflammation - metabolism Mitochondria muscle adaptation Muscle strength Muscle, Skeletal - metabolism Muscular Diseases - metabolism Musculoskeletal system Myopathy Physical fitness Physical training Research Paper Resistance Training - methods Skeletal muscle type 1 diabetes |
Title | Altered muscle mitochondrial, inflammatory and trophic markers, and reduced exercise training adaptations in type 1 diabetes |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1113%2FJP282433 https://www.ncbi.nlm.nih.gov/pubmed/34995365 https://www.proquest.com/docview/2638852630 https://www.proquest.com/docview/2618232890 https://pubmed.ncbi.nlm.nih.gov/PMC9306774 |
Volume | 600 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEB6VnrhAoTzSlmiREL3UxWvveuNjhKiqHFBUBalSD5btnVUraifK4wDqj2dm_WhDQUJcfIhn12tnZjyPz98CfIhRoXOhDnSIOlCxSoPUhSqgYA6tGeWqaNAWX5Pzb2pyqS9bVCV_C9PwQ_QFN7YM76_ZwPOi3YVEMtnAZErZgoqZ6JOhWhwPXUT3DYQwTXuicKNlyztLQz91A7ffRI_Cy8coyYfRq3_9nD2Hq27hDerk--lmXZyWP3_jdPy_O9uDZ21UKsaNGr2AHaxfwv64poy8-iE-Co8T9QX4fbgbc4Mdrag2KxIWFfkE8qG1ZVU-EaSxpGSVb96LvLZivZwvrm9KUTEQaLk68T8umTGW5uh2fBLdVhUit_migQesaC7BJWIhRVcifgWzsy-zz-dBu4dDUPI3vYEzCTPYmTQpI5Qja43SGlOFlBmRNiRopNMlswaSJ0i4LaxNnGtEaZ1LXfwadut5jW9ByBitLDBCRSlQ6HSehCMnaa4yjEoaPoDj7u_MypbfnNd-mzV5Tpx1z3UA73vJRcPp8QeZo04jstaqV1lEzmqk6RjSFP1pskdusuQ1zjcsQxlbzO3bAbxpFKi_CFkCd8v1AMyWavUCzPW9faa-ufac3ymndkbRTXrN-eu6s9lkSkmvkgf_LHkITyM2Ew-sO4Ld9XKD7yjSWhdDeBKp6dBb1tAXwn4BMIUlmQ |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VcoALFMpjSwEjIbg0bRzb8UY9rRDVspSqQovUA1KUjW21osmu9nGg6o9nxokDS0FCXHLYjB0nOzOZb2byGeC1sNI6F6tIxVZFUsgsylwsIwzmrNH9Qk6abouTdPhFjs7U2QYchm9hGn6ILuFGluH9NRk4JaRbKye2gdEpwgUpxC24TRt6ezz1OflZQoizrKMK14q3zLM49iCMXH8X3Qgwb_ZJ_hq_-hfQ0X34Gpbe9J18218tJ_vl1W-sjv95b1twrw1M2aDRpAewYeuHsD2oEZRX39kb5ltFfQ5-G64HVGO3hlWrBQqzCt0CutHakDbvMVRa1LPK1-9ZURu2nE9n5xclq6gXaL7Y8z_OiTQW5wibPrGwWwUrTDFrOgQWOBejLDHjLGSJH8H46P343TBqt3GISvqsN3I6JRI7naVlYnnfGC2Vspm0CI5QIVKruVMlEQeiM0ipMqy0KJS13DiXOfEYNutpbZ8C48IaPrGJlYiCYqeKNO47jnOVcVLi8B68Df9nXrYU57T2y7yBOiIPz7UHrzrJWUPr8QeZ3aASeWvYizxBf9VXeIxxiu40miTVWYraTlckg6BNUAW3B08aDeougsZABXPVA72mW50A0X2vn6kvzj3td0boTku8Sa86f113Ph6dIu6VfOefJV_CneH403F-_OHk4zO4m5DN-D67Xdhczlf2OQZey8kLb2A_AJlPJ80 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5BkRCXUiiPLQWMhODStHFix5vjqmVVFlSt0CJV4hBl47FaQbKrfRyo-uOZcR6wFCTEJYdk7NjJN5MZz-QzwOsYFToX6kCHqAMVqzRIXagCcubQmn6upnW1xVly-lmNzvV5U1XJ_8LU_BDdghtrhrfXrOBz6xolZ7KB0ZiiBRXHt-GOSsI-I_rkU_QzgxCmaccUbrRsiGep7VHbcvNTdMO_vFkm-av76r8_w_vwpR15XXby9XC9mh4WV7-ROv7f1HZgu3FLxaDG0QO4hdVD2B1UFJKX38Ub4QtF_Qr8LlwPOMOOVpTrJQmLkowCGdHKMpYPBEGWUFb67L3IKytWi9n84rIQJVcCLZYH_uSCKWOpj3bLJ9HuVSFym8_r-oAl9SV4jVhI0a4RP4LJ8N3k-DRoNnEICv6pN3AmYQo7kyZFhLJvrVFaY6qQQiOCQ4JGOl0wbSCZgoTzwtrEuUaU1rnUxY9hq5pV-BSEjNHKKUaoKAYKnc7prTtJfRVhVFDzHrxtX2dWNATnPPZvWR3oxFn7XHvwqpOc16Qef5DZbxGRNWq9zCKyVn1Nx5C66C6TQnKWJa9wtmYZCtlizt_24EkNoO4mpAqcLtc9MBvQ6gSY7HvzSnV54Um_U47tjKJJeuT8ddzZZDSmqFfJvX-WfAl3xyfD7OP7sw_P4F7EGuOL7PZha7VY43PyulbTF169fgAlWyaF |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Altered+muscle+mitochondrial%2C+inflammatory+and+trophic+markers%2C+and+reduced+exercise+training+adaptations+in+type+1+diabetes&rft.jtitle=The+Journal+of+physiology&rft.au=Minnock%2C+Dean&rft.au=Annibalini%2C+Giosu%C3%A8&rft.au=Valli%2C+Giacomo&rft.au=Saltarelli%2C+Roberta&rft.date=2022-03-01&rft.issn=1469-7793&rft.eissn=1469-7793&rft.volume=600&rft.issue=6&rft.spage=1405&rft_id=info:doi/10.1113%2FJP282433&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-3751&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-3751&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-3751&client=summon |